Page 165 - Read Online
P. 165

Page 2 of 21               Bradshaw et al. Vessel Plus 2023;7:35  https://dx.doi.org/10.20517/2574-1209.2023.121

               Pathology associated with K  channels can result from decreased or increased function, depending on the
                                       ATP
               specific mutation and subunit affected. Loss of function of K  channels results in hyperinsulinism and
                                                                    ATP
               vascular hypercontractility [16,17] , whereas gain of function leads to prolonged PR intervals, arrhythmias, and
               hypotension [2,3,18-20] . The pathology of Cantu syndrome (hypertrichosis-osteochondrodysplasia-cardiomegaly
               syndrome) results from genetic gain of function of K  channel subunits, resulting in abnormalities
                                                               ATP
               including cardiac enlargement and ventricular hypertrophy, pericardial effusion, pulmonary hypertension,
               and hypertrichosis [11,21] . Understanding the abnormalities in Cantu syndrome is informative with regard to
               the non-pathologic role of K  channels in human physiology . Some pharmacologic agents that activate
                                                                    [22]
                                        ATP
               K  channels may cause some of the same changes as those seen in Cantu syndrome, and this modulation
                 ATP
               of these channels has the potential to be beneficial [11,23,24] .
               The body of literature on the nature and role of K  channels in various tissues has grown steadily over
                                                           ATP
               recent decades. A subset of literature focuses on the role of these channels in cardiac disease . Activation of
                                                                                            [25]
               K  channels is involved in cardioprotection or preservation of the myocardium during stress, such as the
                 ATP
                                                        [26]
               global ischemia imposed during cardiac surgery . The channels are similarly involved in the protection of
               the neural cortex and spinal cord [27-29] . Previous authors have reviewed the early basic science of K
                                                                                                        ATP
               channels [30-33] . In this review, we highlight recent evidence with a focus on the role of these channels in
               cardioprotection and neuroprotection during cardiac surgery.

               STRUCTURE AND FUNCTION OF K  CHANNELS
                                                   ATP
               Cardiac myocytes contain two K  channel entities: one located in the sarcolemmal membrane (sK ) and
                                                                                                   ATP
                                           ATP
               a proposed mitochondrial channel (mitoK ). The structure and function of sK  and mitoK  appear to
                                                                                   ATP
                                                   ATP
                                                                                               ATP
               be related but with important differences [34-36] . The well-characterized sK  channel has been cloned and is
                                                                             ATP
               present at a very high density in the heart (2,000-3,000/myocyte) . The sK  channel is a hetero-octamer
                                                                      [37]
                                                                               ATP
                                                                    +
               of four pore-forming polypeptides of the inwardly rectifying K  channel family Kir6.x and four sulfonylurea
               receptor subunits of the superfamily of ATP-binding cassette transporters [38-40] . The sulfonylurea receptor
               (SUR) subunit represents the site for blockade by sulfonylureas and stimulation by potassium channel
               openers and adenosine diphosphate (ADP). The Kir6.x subunit is the location for inhibition by ATP [38,40] .
               The mitoK  channel may be primarily responsible for the cardioprotection provided by K  channel
                                                                                                ATP
                         ATP
               modulation [26,41] , but the sK  channel is better characterized and may also be involved . The physiological
                                                                                        [42]
                                      ATP
               role of the sK  channel in cardiac tissue involves modulating cellular function in response to stress such as
                          ATP
               metabolic inhibition [25,43] . Specifically, the channel is opened in response to stress and closed (inhibited) in
               the presence of ATP . The function of the mitoK  channel appears to involve organelle response to
                                 [44]
                                                            ATP
               stress, with effects on both the volume and the function of the mitochondria [45-47] .
               The focus of this review is the role function of K  channels in the myocardium. However, K  channels
                                                         ATP
                                                                                                ATP
               are present in cardiac muscle, skeletal muscle, and smooth muscle, and their function in smooth muscle is
               worth noting in this discussion about the cardiovascular effects of K  channels . Diazoxide is a K
                                                                                      [48]
                                                                            ATP
                                                                                                        ATP
               channel opener that has been found to cause substantial arterial and arteriolar dilatation [49,50] . This agent was
               first used clinically as an antihypertensive agent before its potential as a cardioprotective agent was
                       [51]
               identified . The side effects of diazoxide have limited its clinical use for hypertension, though it is still used
               clinically primarily to treat hypoglycemia [52-55] . The role of K  channels in causing hypotension is primarily
                                                                 ATP
               attributed to the vascular smooth muscle cells ; however, these channels are also found in vascular
                                                         [2,3]
               endothelial cells, and the action in endothelial cells may contribute to the effects on vascular tone [56,57] .
   160   161   162   163   164   165   166   167   168   169   170